Compass Pathways 

Compass Pathways 

Yahoo Finance • 23 days ago

Compass Pathways Working with U.S. Department of Veterans Affairs for Investigational Study of Psilocybin

LONDON & NEW YORK, August 06, 2026--(BUSINESS WIRE)--Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to unlocking urgently needed new treatment options in mental health care, announced today it is working with the U.... Full story

Yahoo Finance • 23 days ago

Compass Pathways PLC (CMPS) (Q2 2026) Earnings Call Highlights: Strong Cash Position and NDA ...

This article first appeared on GuruFocus. Cash Position: $433 million in cash on hand as of June 30, 2026, expected to fund operations through launch and into 2028. Regulatory Milestone: Rolling NDA submission for COMP360 in treatment-res... Full story

Yahoo Finance • 24 days ago

Here are the major earnings before the open Wednesday

Major earnings expected before the bell on Wednesday include: * The Walt Disney Company (DIS [https://seekingalpha.com/symbol/DIS]) * Eli Lilly and Company (LLY [https://seekingalpha.com/symbol/LLY]) * Shopify (SHOP [https://seeking... Full story

Yahoo Finance • last month

Cathie Wood's Ark Invest boosts stakes in Tesla, SpaceX, Meta, trimming Figma, Shopify

Cathie Wood’s ARK Invest’s largest purchase during July 20-24 was Tesla (TSLA [https://seekingalpha.com/symbol/TSLA]), with the firm acquiring an additional $52.7M stake after a steep sell-off post weaker-than-expected Q2 earnings report.... Full story

Yahoo Finance • last month

Psychedelic Therapy Meets M&A: Fireside Chat with Jupiter Neurosciences CEO Christer Rosén & President Alison Silva

Watch Fireside Chat Below, or Click HERE: IPO Edge hosted a fireside chat with Jupiter Neurosciences, Inc. (Nasdaq: JUNS) Chairman, Chief Executive Officer and Co-founder Christer Rosén and Alison Silva, President and Chief Operations Off... Full story

Yahoo Finance • last month

At a glance: stocks gapping up premarket

[Wall Street New York City] aluxum/E+ via Getty Images Here's a quick look at the stocks that are seeing gap-up moves before the bell Thursday. Stock index futures fell on Thursday, with Nasdaq futures leading declines amid weakness in g... Full story

Yahoo Finance • last month

The Race to Commercialize the World’s Most Powerful Psychedelic

An obscure psychedelic is drawing intense interest from the pharmaceutical industry. WSJ explores why companies are betting hundreds of millions of dollars on the therapeutic potential of a toad poison. View Comments... Full story

Yahoo Finance • 2 months ago

Cathie Wood reshuffles portfolio ahead of Q2, buys SpaceX, Eli Lilly, Meta; pares AMD, Roku

Cathie Wood's ARK Invest's largest purchase during the last week by value was Elon Musk's Space Exploration Technologies (SPCX [https://seekingalpha.com/symbol/SPCX]), adding a combined 349K shares across ARKK, ARKQ, ARKW and ARKX for ~$52... Full story

Yahoo Finance • 2 months ago

Cathie Wood Dumps AMD, Doubles Down on Meta Stock

This article first appeared on GuruFocus. Cathie Wood's ARK added to its Meta Platforms (NASDAQ:META) position while further reducing its stake in Advanced Micro Devices (NASDAQ:AMD), according to the firm's daily trade disclosure release... Full story

Yahoo Finance • 2 months ago

Kailera Therapeutics Appoints Kathleen Tregoning as Chief Corporate Affairs Officer

WALTHAM, Mass., June 29, 2026 (GLOBE NEWSWIRE) -- Kailera Therapeutics, Inc., a clinical-stage biotechnology company focused on elevating the next era of obesity care, today announced the appointment of Kathleen Tregoning as Chief Corpor... Full story

Yahoo Finance • 3 months ago

FundaMental Pharma appoints depression drug developer Dr. Hans Eriksson as Chief Medical Officer to advance its lead treatment-resistant depression candidate

FundaMental Pharma GmbH Exceptional track record across multiple clinical development programs for depression, three of which have resulted in regulatory approvals Appointment strengthens confidence in clinical readiness and execution as... Full story

Yahoo Finance • 4 months ago

Jefferies analyst says Trump's executive order on psychedelics is an 'official stamp of validation' for investors

Psychedelic drugmakers just got a jolt that Wall Street couldn't ignore. After President Donald Trump signed an executive order (1) aimed at fast-tracking research and access to psychedelic therapies as a form of mental-health treatment, i... Full story

Yahoo Finance • 4 months ago

Why Compass Pathways Stock Rocketed 40% Today

A White House Executive Order over the weekend has some healthcare company stocks soaring today. One big winner is Compass Pathways(NASDAQ: CMPS). Shares of the biotechnology company rocketed more than 50% this morning and were still highe... Full story

Yahoo Finance • 4 months ago

Stocks making the biggest moves midday: Stanley Black & Decker, American Airlines, Dow, Marvell Technology & more

Check out the companies making the biggest moves in midday trading: Stanley Black & Decker — The power toolmaker jumped more than 4% after it said recent changes to Section 232 tariffs aren't supposed to have a material impact on its full-... Full story

Yahoo Finance • 4 months ago

Trump Just Fast-Tracked Psychedelic Treatments: 3 Under-the-Radar Stocks That Could Be About to Soar

Over the weekend, President Donald Trump fast-tracked the approval process for psychedelic treatments for mental illnesses. Trump signed an order that directs the Food and Drug Administration (FDA) to ease restrictions on and speed up rev... Full story

Yahoo Finance • 4 months ago

Marvell–Google AI talks, Trump EO boosts psychedelic stocks

Yahoo Finance's Julie Hyman and Brooke DiPalma takes a closer look at some of Monday morning's trending tickers and stories. Marvell (MRVL) stock is surging on reports that the company is in talks with Google (GOOG, GOOGL) to develop arti... Full story

Yahoo Finance • 4 months ago

Stocks making the biggest moves premarket: American Airlines, Marvell Technology, Strategy & more

Check out the companies making the biggest moves premarket: Airlines — The group was under pressure Monday as investors worry that renewed U.S.-Iran tensions will keep energy prices elevated and push consumers to travel less. American Airl... Full story

Yahoo Finance • 4 months ago

Trump issues executive order on psychedelic drugs

[President Trump Signs Executive Order At The White House] Tasos Katopodis/Getty Images News President Donald Trump on Saturday signed an executive order to expedite access to research and treatments ​based on psychedelic drugs, a move th... Full story

Yahoo Finance • 4 months ago

Trump Trade: President to sign order on psychedelic used for PTSD

Catch up on the top industries and stocks that were impacted, or were predicted to be impacted, by the comments, actions and policies of President Donald Trump with this daily recap compiled by The Fly. Claim 30% Off TipRanks Unlock hed... Full story

Yahoo Finance • 5 months ago

Compass Pathways Announces Fourth Quarter and Full-Year 2025 Financial Results and Business Highlights

COMP360 is the first classic psychedelic1 to consistently achieve a highly statistically significant result and clinically meaningful effect in treatment resistant depression (TRD), with a generally well-tolerated and safe profile Across t... Full story